Physician profile
Stacy Forrestt
NPI 1881702298
$1,513.17
in general payments reported to CMS, 2019-2025
11 companies · $871 in 2025
The $871 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.54 · 2022: $21.02 · 2023: $124 · 2024: $486 · 2025: $871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,480.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $649.29 | 2023-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $300.08 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $165.93 | 2024 | Nalu Neurostimulation System |
| Mml US, INC. | $110.08 | 2025 | Reactiv8 |
| Globus Medical, INC. | $69.91 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $69.26 | 2024-2025 | |
| Averitas Pharma INC. | $67.88 | 2024 | Qutenza |
| Nevro Corp. | $26.72 | 2024 | Senza |
| Ibsa Pharma INC. | $24.13 | 2025 | Flector, Tirosint, Licart |
| Abbott Laboratories | $15.70 | 2025 | Eterna |
| Vertex Pharmaceuticals Incorporated | $14.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Forrestt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.